Silence Therapeutics (SLN) Prepaid Assets (2018 - 2026)
Silence Therapeutics recorded quarterly Prepaid Assets of $10.6 million in Q1 2026, down 8.49% quarter-over-quarter from $11.5 million in Q4 2025, and down 35.7% year-over-year from $16.4 million in Q1 2025.
Silence Therapeutics' Prepaid Assets history runs 9 years deep, the most recent figure standing at $10.6 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 35.7% year-over-year to $10.6 million; the TTM figure through Mar 2026 stood at $10.6 million (down 35.7% YoY), while the FY2025 annual figure was $11.5 million, down 21.32% from the prior year.
- Prepaid Assets came in at $10.6 million for Q1 2026 at Silence Therapeutics, down from $11.5 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $16.4 million in Q1 2025 to a low of $8.3 million in Q1 2022.
- A 5-year average of $12.1 million and a median of $11.5 million in 2025 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 206.81% in 2022 and sank 40.43% in 2025, its largest moves.
- Silence Therapeutics' Prepaid Assets stood at $9.6 million in 2022, then climbed by 17.88% to $11.3 million in 2023, then rose by 29.34% to $14.7 million in 2024, then fell by 21.32% to $11.5 million in 2025, then decreased by 8.49% to $10.6 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $10.6 million, $11.5 million, and $9.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.56 Mn |
| Dec 31, 2025 | 11.54 Mn |
| Sep 30, 2025 | 9.26 Mn |
| Jun 30, 2025 | 14.36 Mn |
| Mar 31, 2025 | 16.42 Mn |
| Dec 31, 2024 | 14.66 Mn |
| Sep 30, 2024 | 15.54 Mn |
| Jun 30, 2024 | 15.45 Mn |
| Mar 31, 2024 | 12.87 Mn |
| Dec 31, 2023 | 11.34 Mn |
| Sep 30, 2023 | 14.34 Mn |
| Jun 30, 2023 | 8.47 Mn |
| Mar 31, 2023 | 10.19 Mn |
| Dec 31, 2022 | 9.62 Mn |
| Sep 30, 2022 | 12.19 Mn |
| Jun 30, 2022 | 10.47 Mn |
| Mar 31, 2022 | 8.33 Mn |
| Dec 31, 2021 | 5.81 Mn |
| Sep 30, 2021 | 3.97 Mn |
| Jun 30, 2021 | 5.04 Mn |
| Dec 31, 2020 | 5.20 Mn |
| Jun 30, 2020 | 2.57 Mn |
| Dec 31, 2019 | 554,147.43 |
| Jun 30, 2019 | 995,605.97 |
| Dec 31, 2018 | 662,685.12 |